Annales de cardiologie et d'angeiologie最新文献

{"title":"Cardiomyopathie dilatée hypocalcémique réversible induite par un hypoparathyroïdisme secondaire décompensé après une infection à la Covid-19 : à propos d’un cas","authors":"Samia Ejjebli,&nbsp;Alaa Al Timimi,&nbsp;Yassine Ettagmouti,&nbsp;Ghali Benouna,&nbsp;Salim Arous,&nbsp;Abdenasser Drighil,&nbsp;Rachida Habbal","doi":"10.1016/j.ancard.2025.101899","DOIUrl":"10.1016/j.ancard.2025.101899","url":null,"abstract":"<div><h3>Introduction</h3><div>Hypocalcemia, though rare, can lead to heart failure with reduced ejection fraction and dilated cardiomyopathy. It may result from various etiologies, and its manifestations range from mild to life-threatening. Cardiovascular complications of hypocalcemia include QT interval prolongation, ventricular arrhythmias, and heart failure.we report a rare case of reversible hypocalcemic dilated cardiomyopathy.</div></div><div><h3>Case Report</h3><div>We present the case of a 41-year-old woman with secondary hypoparathyroidism following thyroidectomy in 2018. She was treated with levothyroxine, calcitriol, and calcium and vitamin D supplements. Following a Covid-19 infection in May 2021, her hypoparathyroidism decompensated, leading to severe hypocalcemia, which was inadequately managed. Five months later, she presented with worsening dyspnea, orthopnea, and bilateral lower limb edema. Clinical examination revealed positive Chvostek and Trousseau’s signs, indicating severe hypocalcemia. ECG showed sinus tachycardia with QT prolongation, and echocardiography revealed a dilated left ventricle with an ejection fraction (EF) of 29%. Despite normal coronary angiography, a CT scan showed bilateral pleural effusion and superior vena cava thrombosis. Laboratory findings confirmed hypocalcemia with elevated phosphorus and low parathyroid hormone levels. Intravenous calcium correction and heart failure management led to symptomatic improvement and normalization of serum calcium within one week. Echocardiography showed gradual recovery, with EF improving to 38% at 8 weeks and 57% after 6 months.</div></div><div><h3>Discussion</h3><div>Calcium plays a critical role in cardiac contractility, and its deficiency can severely impact myocardial function. Hypocalcemia following thyroidectomy is a known complication and can worsen during systemic infections like Covid-19. While hypocalcemia-induced cardiomyopathy is reversible with proper treatment, it requires early recognition and aggressive correction. *</div></div><div><h3>Conclusion</h3><div>This case highlights the importance of monitoring calcium levels in patients with hypoparathyroidism, especially in the context of systemic infections, to prevent potentially life-threatening complications like hypocalcemic cardiomyopathy. Proper diagnosis and treatment of hypocalcemia can lead to full recovery of cardiac function</div></div>","PeriodicalId":7899,"journal":{"name":"Annales de cardiologie et d'angeiologie","volume":"74 3","pages":"Article 101899"},"PeriodicalIF":0.3,"publicationDate":"2025-05-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143918052","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Intérêt de la télésurveillance non invasive dans le contrôle du poids, des symptômes et la réduction des hospitalisations chez les patients insuffisants cardiaques : analyse d'une cohorte française sur 1 an","authors":"Jérôme Costa,&nbsp;Priscillia Durdon,&nbsp;Julie Dangy,&nbsp;Lucie Lombardot,&nbsp;Louise Trousselle,&nbsp;Marine Pierre,&nbsp;Pierre Nazeyrollas,&nbsp;Damien Metz","doi":"10.1016/j.ancard.2025.101892","DOIUrl":"10.1016/j.ancard.2025.101892","url":null,"abstract":"<div><h3>Background</h3><div>Heart failure (HF) is a severe condition associated with high rates of hospitalization and mortality. Early outpatient detection of symptoms and weight gain through remote medical monitoring of HF (HF-RM) could improve patient prognosis.</div></div><div><h3>Objectives</h3><div>To evaluate the effectiveness of HF-RM in managing congestion in HF outpatients and to analyze event rates over 12 months (HF-related hospitalizations and all-cause mortality), as well as associated costs.</div></div><div><h3>Methods</h3><div>We included patients enrolled in the HF-RM at our hospital from July 2020 to December 2022. For each patient, HF-RM relied on daily transmission of weight and symptoms via a connected scale. Any alerts related to weight gain or the onset of new symptoms were managed within 48 hours by the specialized HF team, including a telephone contact, NT-proBNP testing, and treatment adjustment if necessary. Data on HF-related hospitalizations and vital status were collected over a 12-month period before and after the implementation of HF-RM. Event rates were compared to expected values at the onset of HF-RM, based on patient profiles and data from the ESC-HF-LT registry. Cost analysis included costs associated with HF-RM, the specialized HF nurse, biological tests, and HF hospitalizations.</div></div><div><h3>Results</h3><div>Among the 147 patients included, the average age was 60 ± 12 years, and 75% were male. The average ejection fraction (EF) was 33 ± 11%, with 76% of patients presenting with reduced EF. During the HF-RM period, 85 alerts (54% of patients) led to a significant reduction in weight and symptoms within 30 days. The hospitalization rate decreased from 44.9% before the initiation of HF-RM to 11.6% afterward (p &lt; 0.0001). The 12-month event rate was 15%, significantly lower than the expected 24.5% (p = 0.0002). The absence of transmitted alerts was strongly correlated with the absence of events (negative predictive value of 95.2%). The number of days spent at home increased, and costs significantly decreased.</div></div><div><h3>Conclusion</h3><div>HF-RM is associated with improved outpatient congestion control, reduced hospitalizations, and decreased healthcare costs. Further prospective, randomized studies are needed to better assess the impact of HF-RM on the progression of HF and its costs.</div></div>","PeriodicalId":7899,"journal":{"name":"Annales de cardiologie et d'angeiologie","volume":"74 3","pages":"Article 101892"},"PeriodicalIF":0.3,"publicationDate":"2025-05-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143906775","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Réadaptation Cardiovasculaire au Centre Hospitalo-Universitaire de Conakry : Enquête auprès des Médecins","authors":"Ibrahima Sory Sylla,&nbsp;Mamadou Barry,&nbsp;Abdoulaye Camara,&nbsp;Aïssatou Barry,&nbsp;Mamadou Bachir Bah,&nbsp;Ousmane Mamadama Camara,&nbsp;Alpha Koné,&nbsp;Ibrahima Sory Barry,&nbsp;Djibril Sylla,&nbsp;Elhadj Yaya Baldé,&nbsp;Mamadou Dadhi Baldé","doi":"10.1016/j.ancard.2025.101901","DOIUrl":"10.1016/j.ancard.2025.101901","url":null,"abstract":"","PeriodicalId":7899,"journal":{"name":"Annales de cardiologie et d'angeiologie","volume":"74 3","pages":"Article 101901"},"PeriodicalIF":0.3,"publicationDate":"2025-05-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143911722","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Erratum au résumé : « Intérêt du dépistage précoce de la maladie de Fabry » [Ann Cardiol Angeiol (Paris) 2024 ; 73/5 (2024), 101828]","authors":"S. Aroua ,&nbsp;M. Boukheloua","doi":"10.1016/j.ancard.2025.101897","DOIUrl":"10.1016/j.ancard.2025.101897","url":null,"abstract":"","PeriodicalId":7899,"journal":{"name":"Annales de cardiologie et d'angeiologie","volume":"74 3","pages":"Article 101897"},"PeriodicalIF":0.3,"publicationDate":"2025-05-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143906776","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Accessibilité au TAVI dans un centre dépourvu de chirurgie cardiaque : Un exemple Corse","authors":"F. Ferrandi ,&nbsp;F. Collart ,&nbsp;A. Cribier ,&nbsp;H. Eltchaninoff ,&nbsp;P. Luporsi","doi":"10.1016/j.ancard.2025.101898","DOIUrl":"10.1016/j.ancard.2025.101898","url":null,"abstract":"&lt;div&gt;&lt;h3&gt;Introduction&lt;/h3&gt;&lt;div&gt;La sténose aortique est la valvulopathie la plus fréquente en France. Sa prévalence augmente avec l'âge, touchant plus de 10 % des personnes de plus de 70 ans. Une fois symptomatique, le pronostic est sombre, avec un taux de mortalité proche de 50 % dans les 2 ans. Les recommandations européennes pour la prise en charge des sténoses aortiques sévères recommandent une prise en charge rapide dès l'apparition des symptômes. Cependant, la sténose aortique reste largement sous-diagnostiquée et sous-traitée, notamment avec un accès aux soins limité et de plus en plus complexe en raison de la géographie. L'objectif principal de ce travail est d'analyser la prise en charge de tous les patients atteints de sténose aortique sévère symptomatique adressés au CHU de Bastia de janvier 2019 à décembre 2022. L'objectif secondaire est d'étudier les facteurs qui retardent la prise en charge et d'évaluer les conséquences sur l'évolution de ces patients.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Matériels et méthodes&lt;/h3&gt;&lt;div&gt;Les données de 151 patients diagnostiqués avec une sténose aortique sévère symptomatique entre le 1er janvier 2019 et le 31 décembre 2022 au CHU de Bastia ont été recueillies rétrospectivement.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Résultats&lt;/h3&gt;&lt;div&gt;Notre population était composée à 69 % d'hommes, d'âge moyen de 80 ans. Le risque opératoire était faible, avec un Euroscore moyen de 5 (Euroscore 0-45). La grande majorité des patients étaient symptomatiques, avec une dyspnée d'effort NYHA &gt;2 (76 %). La FEVG moyenne était de 55 %, ce qui signifie que la plupart des patients avaient une fraction d'éjection ventriculaire gauche préservée. Une donnée significative que nous avons recueillie était le délai d'attente avant l'intervention. Parmi les patients inclus (102), le délai entre le diagnostic et l'implantation du TAVI était en moyenne de 162 jours (plus de 5 mois). Le délai entre la coronarographie et l'implantation du TAVI était d'environ 109 jours, contre une moyenne nationale de 70 jours. Parmi les patients inclus, 13 % sont décédés en attente et 7 % ont refusé le traitement proposé. L’étude des délais de bilan préopératoire n’a pas identifié de délai d’examen particulier comme cause principale, mais nous pouvons conclure que le processus global contribue à ces résultats.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Conclusion&lt;/h3&gt;&lt;div&gt;Cette étude révèle qu’un quart des patients atteints de sténose aortique sévère dans cette population ne peuvent actuellement pas bénéficier d’un remplacement valvulaire percutané. Une prise en charge sur place, sans recours à la chirurgie cardiaque, pourrait être envisagée pour réduire les délais d’attente et la mortalité, comme cela se fait ailleurs en Europe.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Introduction&lt;/h3&gt;&lt;div&gt;Aortic stenosis is the most common valvular disease in France. Its prevalence increases with age, affecting more than 10 % of people over 70 years old. Once symptomatic, the prognosis is grim, with a mortality rate close to 50 % within 2 years","PeriodicalId":7899,"journal":{"name":"Annales de cardiologie et d'angeiologie","volume":"74 3","pages":"Article 101898"},"PeriodicalIF":0.3,"publicationDate":"2025-05-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143906774","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}